Literature DB >> 30250985

Contribution of the clock gene DEC2 to VEGF mRNA upregulation by modulation of HIF1α protein levels in hypoxic MIO-M1 cells, a human cell line of retinal glial (Müller) cells.

Naoki Kusunose1,2, Takahiro Akamine3,4, Yoshiyuki Kobayashi5, Shigeo Yoshida5, Kenichi Kimoto3, Sai Yasukochi4, Naoya Matsunaga6, Satoru Koyanagi6, Shigehiro Ohdo4, Toshiaki Kubota3.   

Abstract

PURPOSE: Clock genes are components of the molecular clock. Their malfunction is thought to increase the risk of numerous diseases, including cancer. Vascular endothelial growth factor (VEGF) has a pivotal role in angiogenesis, and its expression levels are controlled by clock genes in tumor cells. Ophthalmic diseases such as age-related macular degeneration, proliferative diabetic retinopathy, and neovascular glaucoma are also associated with abnormal angiogenesis followed by upregulation of VEGF in the eye. In the present study, we aimed to uncover the relationship between clock genes and VEGF in the eye. STUDY
DESIGN: Laboratory investigation
METHODS: Oxygen-induced retinopathy (OIR) mice were prepared to mimic hypoxic conditions in the eye. Deferoxamine (DFO) was used to mimic hypoxic conditions in human Müller cell line MIO-M1 cells. Expression levels of mRNA and protein were quantified by quantitative reverse transcription polymerase chain reaction and Western blot analysis, respectively.
RESULTS: In the retinas of OIR mice, the expression levels of Vegf and the clock gene Dec2 increased transiently, and their temporal profiles were correlated. Knockdown of DEC2 resulted in a significant (26.7%) reduction of VEGF expression in MIO-M1 cells under hypoxia-mimicking conditions induced by DFO (P < .05). Levels of HIF1α protein were also reduced significantly, by 60.2%, in MIO-M1 cells treated with siRNA against the DEC2 gene (P < .05). Moreover, HIF1α levels showed a significant (2.5-fold) increase in MIO-M1 cells overexpressing DEC2 (P < .05).
CONCLUSION: DEC2 could upregulate retinal VEGF gene expression through modulation of HIF1α levels under hypoxic conditions.

Entities:  

Keywords:  Clock genes; DEC2; HIF1α; Müller cells; VEGF

Mesh:

Substances:

Year:  2018        PMID: 30250985     DOI: 10.1007/s10384-018-0622-5

Source DB:  PubMed          Journal:  Jpn J Ophthalmol        ISSN: 0021-5155            Impact factor:   2.447


  44 in total

Review 1.  The mouse retina as an angiogenesis model.

Authors:  Andreas Stahl; Kip M Connor; Przemyslaw Sapieha; Jing Chen; Roberta J Dennison; Nathan M Krah; Molly R Seaward; Keirnan L Willett; Christopher M Aderman; Karen I Guerin; Jing Hua; Chatarina Löfqvist; Ann Hellström; Lois E H Smith
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-06       Impact factor: 4.799

Review 2.  Emerging evidence for the interrelationship of xenobiotic exposure and circadian rhythms: a review.

Authors:  F L Lim; R A Currie; G Orphanides; J G Moggs
Journal:  Xenobiotica       Date:  2006 Oct-Nov       Impact factor: 1.908

3.  Chronopharmacology focused on biological clock.

Authors:  Shigehiro Ohdo
Journal:  Drug Metab Pharmacokinet       Date:  2007-02-25       Impact factor: 3.614

4.  Shift work, jet lag, and female reproduction.

Authors:  Megan M Mahoney
Journal:  Int J Endocrinol       Date:  2010-03-08       Impact factor: 3.257

Review 5.  The role of clock genes and circadian rhythm in the development of cardiovascular diseases.

Authors:  Norihiko Takeda; Koji Maemura
Journal:  Cell Mol Life Sci       Date:  2015-05-14       Impact factor: 9.261

Review 6.  Current treatment strategies and nanocarrier based approaches for the treatment and management of diabetic retinopathy.

Authors:  Kousalya Selvaraj; Kuppusamy Gowthamarajan; Veera Venkata Satyanarayana Reddy Karri; Uday K Barauah; Vanka Ravisankar; Gifty M Jojo
Journal:  J Drug Target       Date:  2017-01-25       Impact factor: 5.121

Review 7.  Histone deacetylase inhibitors: the epigenetic therapeutics that repress hypoxia-inducible factors.

Authors:  Shuyang Chen; Nianli Sang
Journal:  J Biomed Biotechnol       Date:  2010-12-05

8.  Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer.

Authors:  Christopher G Willett; Yves Boucher; Emmanuelle di Tomaso; Dan G Duda; Lance L Munn; Ricky T Tong; Daniel C Chung; Dushyant V Sahani; Sanjeeva P Kalva; Sergey V Kozin; Mari Mino; Kenneth S Cohen; David T Scadden; Alan C Hartford; Alan J Fischman; Jeffrey W Clark; David P Ryan; Andrew X Zhu; Lawrence S Blaszkowsky; Helen X Chen; Paul C Shellito; Gregory Y Lauwers; Rakesh K Jain
Journal:  Nat Med       Date:  2004-01-25       Impact factor: 53.440

9.  Transcriptional activation of HIF-1 by RORalpha and its role in hypoxia signaling.

Authors:  Eun-Jin Kim; Young-Gun Yoo; Woo-Kyeom Yang; Young-Soun Lim; Tae-Young Na; In-Kyu Lee; Mi-Ock Lee
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-07-24       Impact factor: 8.311

10.  Differentially Expressed in Chondrocytes 2 (DEC2) Increases the Expression of IL-1β and Is Abundantly Present in Synovial Membrane in Rheumatoid Arthritis.

Authors:  Juri Olkkonen; Vesa-Petteri Kouri; Joel Hynninen; Yrjö T Konttinen; Jami Mandelin
Journal:  PLoS One       Date:  2015-12-28       Impact factor: 3.240

View more
  1 in total

1.  Periostin in Angiogenesis and Inflammation in CRC-A Preliminary Observational Study.

Authors:  Agnieszka Kula; Miriam Dawidowicz; Sylwia Mielcarska; Paweł Kiczmer; Magdalena Chrabańska; Magdalena Rynkiewicz; Elżbieta Świętochowska; Dariusz Waniczek
Journal:  Medicina (Kaunas)       Date:  2022-01-08       Impact factor: 2.430

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.